P
Prime Medicine, Inc. (PRME)
NGM – Real Time Price. Currency in USD
3.43
+0.25 (7.86%)
At close: Jun 26, 2026, 4:00 PM EDT
3.43
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:05 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
3.43
+0.25 (7.86%)
At close: Jun 26, 2026, 4:00 PM EDT
3.43
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:05 PM EDT
No Data
There are no news for this stock.
Total debt $114.5M significantly exceeds cash reserves ($64.1M), raising financial stability concerns
Total current assets $137.9M exceed Total current liabilities $36.3M, highlighting excellent liquidity
Debt-to-equity ratio (1.5) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$42.9M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.80 | 6.05 | 10 | |
| Quick ratio | 3.80 | 5.63 | 10 | |
| Debt to Equity | 1.49 | 0.30 | 5.0 | |
| Debt to Assets | 0.39 | 1.04 | 6.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 6.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | 3M | 5M | 4M |
| Gross Profit | -12M | -5M | -3M | -3M | -3M |
| Operating Income | -117M | -191M | -202M | -208M | -207M |
| Net Income | -122M | -198M | -196M | -201M | -198M |
| EBITDA | -105M | -187M | -196M | -201M | -199M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 112.23 | 37.5 | 10 |
| Next quarter | 524.2 | 27.07 | 10 |
| Current year | 176.99 | 25.99 | 10 |
| Next year | 75.49 | 9.17 | 8.0 |
| Weighted average score | 9.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 2.15 | -6.59 | -27.26 | -14.31 | 1.5 |
| Y/Y | -41.12 | 5.33 | 30 | 16.29 | 6.3 |
| 3y average | 684.43 | -21.38 | 30.15 | -6.93 | 5.5 |
| 5y average | 590.46 | -957.45 | 30.15 | -165.2 | 5.5 |
| Weighted average score | 4.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |